Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis

ME Flacco, C Acuti Martellucci… - European journal of …, 2022 - Wiley Online Library
Introduction A precise estimate of the frequency and severity of SARS‐CoV‐2 reinfections
would be critical to optimize restriction and vaccination policies for the hundreds of millions …

Severity and outcomes of SARS-CoV-2 reinfection compared with primary infection: a systematic review and meta-analysis

J Deng, Y Ma, Q Liu, M Du, M Liu, J Liu - International journal of …, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection has brought
new challenges to the global prevention and control of coronavirus disease 2019 (COVID …

The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2

JP Townsend, HB Hassler, P Sah… - Proceedings of the …, 2022 - National Acad Sciences
The durability of vaccine-mediated immunity to SARS-CoV-2, the durations to breakthrough
infection, and the optimal timings of booster vaccination are crucial knowledge for pandemic …

SARS-CoV-2 reinfection and severity of the disease: a systematic review and meta-analysis

NN Nguyen, YN Nguyen, VT Hoang, M Million… - Viruses, 2023 - mdpi.com
Since the discovery of SARS-CoV-2, changes in genotype and reinfection with different
variants have been observed in COVID-19-recovered patients, raising questions around the …

[HTML][HTML] Covid-19: virology, variants, and vaccines

M Young, H Crook, J Scott, P Edison - BMJ medicine, 2022 - ncbi.nlm.nih.gov
Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …

COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis

ME Flacco, C Acuti Martellucci, V Baccolini… - Frontiers in …, 2022 - frontiersin.org
The addictive protection against SARS-CoV-2 reinfection conferred by vaccination, as
compared to natural immunity alone, remains to be quantified. We thus carried out a meta …

Is there less alteration of smell sensation in patients with omicron SARS-CoV-2 variant infection?

JJ Rodriguez-Sevilla, R Güerri-Fernádez… - Frontiers in …, 2022 - frontiersin.org
The ongoing pandemic Coronavirus Disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern in terms of …

Inactivated vaccine Covaxin/BBV152: A systematic review

TI Ahmed, S Rishi, S Irshad, J Aggarwal… - Frontiers in …, 2022 - frontiersin.org
We systematically reviewed and summarized studies focusing on Bharat Biotech's Whole
Virion Inactivated Corona Virus Antigen BBV152 (Covaxin), which is India's indigenous …

COVID-19 infection, and reinfection, and vaccine effectiveness against symptomatic infection among health care workers in the setting of omicron variant transmission …

S Malhotra, K Mani, R Lodha, S Bakhshi… - The Lancet Regional …, 2022 - thelancet.com
Summary Background Surge of SARS CoV-2 infections ascribed to omicron variant began in
December 2021 in New Delhi. We determined the infection and reinfection density in a …

COVID-19 booster dose coverage and hesitancy among older adults in an urban slum and resettlement colony in Delhi, India

N Sharma, S Basu, H Lalwani, S Rao, M Malik, S Garg… - Vaccines, 2023 - mdpi.com
Background: The high prevalence of vaccine booster hesitancy, with the concomitant
waning of humoral vaccine or hybrid immunity, and the emergence of SARS-CoV-2 variants …